Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration

The growing incidence of infections caused by Enterobacteriaceae producing ESBLs has led to increased use of carbapenems. Temocillin, which resists most β-lactamases, may be a useful alternative. The aim of this study was to assess the pharmacokinetics and target attainment rates of 6 g of temocilli...

Ausführliche Beschreibung